Right time to add pharma stocks in your portfolio ?
DSIJ Intelligence / 13 May 2016
With BSE Healthcare index down by almost 6 percent over a 1 year period, and several of the pharma stocks available at cheaper valuations due to heavy correction in stock prices, experts believe it may be opportune time for long term investors to focus on select pharma stocks.
With BSE Healthcare index down by almost 6 percent over a 1 year period, and several of the pharma stocks available at cheaper valuations due to heavy correction in stock prices, experts believe it may be opportune time for long term investors to focus on select pharma stocks.
Several stocks like Sun Pharma , Cipla, Divi's Laboratories, Caplin Point Lab , Glenmark Pharma , Aurobindo Pharma, Bal Pharma, etc., are down on YTD basis.
Pharma Stock's performance
The Pharma stocks have been reeling under pressure due to the USFDA issues. It is widely believed that Indian pharma companies will gear upto the US standards and USFDA will be at best a temporary problem plaguing the industry.
According to reports the Pharma industry growth has slowed down for the month of March in CY16, but the potential is intact as the export related opportunity to several geographies harbingers the earning potential for several pharma companies.